Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAdvanced Medical Solutions Group Regulatory News (AMS)

Share Price Information for Advanced Medical Solutions Group (AMS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 213.00
Bid: 213.50
Ask: 214.50
Change: 2.50 (1.19%)
Spread: 1.00 (0.468%)
Open: 205.00
High: 215.00
Low: 205.00
Prev. Close: 210.50
AMS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

9 Jun 2011 15:58

RNS Number : 1844I
Advanced Medical Solutions Grp PLC
09 June 2011
 



 

 

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

 

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

ADVANCED MEDICAL SOLUTIONS GRO

 

2 Reason for the notification (please tick the appropriate box or boxes):

 

An acquisition or disposal of voting rights

X

 

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

 

An event changing the breakdown of voting rights

 

Other (please specify):

 

3. Full name of person(s) subject to the notification obligation:

 

AXA S.A. 25 Avenue Matignon, 75008 Paris and its group of companies

4. Full name of shareholder(s) (if different from 3.):

 

5. Date of the transaction and date on which the threshold is crossed or reached:

 

08/06/2011

6. Date on which issuer notified:

 

09/06/2011

7. Threshold(s) that is/are crossed or reached:

 

10%

 

8. Notified details:

A: Voting rights attached to shares

 

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights

Direct

Direct

Indirect

Direct

Indirect

15,307,350

15,307,350

0

0

16,827,350

0.00

10.87

453659

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

 

Type of financialinstrument

Expirationdate

Exercise/ConversionPeriod

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

 

% of votingrights

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

 

Type of financialinstrument

Exerciseprice

Expirationdate

Exercise/Conversionperiod

Number of votingrights instrumentrefers to

% of voting rights

 

Nominal

Delta

 

 

Total (A+B+C)

 

Number of voting rights

Percentage of voting rights

16,827,350

10.87%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable:

 

Name of the Company/Fund 
Number of Shares
% of issued
share capital
AXA IM Paris
 
Indirect
550,000.00
0.355437
 
 
 
AXA IM UK
 
Indirect
16,277,350.00
10.519222
 
 
 
 
 
 
Total Direct
Total Indirect
0
16,827,350
0.00000
10.87466
TOTAL
16,827,350
10.87466

 

Proxy Voting:

 

10. Name of the proxy holder:

 

11. Number of voting rights proxy holder will cease to hold:

 

12. Date on which proxy holder will cease to hold voting rights:

 

 

13. Additional information:

 

14. Contact name:

 

Dimitrios Tsamis

15. Contact telephone number:

 

020 7003 2806

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUKRSRAAANRAR
Date   Source Headline
31st Oct 20227:00 amRNSLiquiBandFix8® PMA application accepted by FDA
14th Sep 20227:00 amRNSInterim Results
8th Sep 20224:53 pmRNSBlock listing announcement
17th Aug 20227:00 amRNSNotice of Interim Results
1st Aug 20227:00 amRNSDirectorate Change
6th Jul 20227:00 amRNSHalf Year Trading Update
8th Jun 20221:52 pmRNSResults of Annual General Meeting
8th Jun 20227:00 amRNSAnnual General Meeting
31st May 20224:03 pmRNSTotal Voting Rights
25th May 20227:00 amRNSAMS announces US approval for LiquiBand® XL
13th May 20226:08 pmRNSDirector- PDMR Dealing Announcement
29th Apr 20225:43 pmRNSAnnual Report, Notice of AGM and Board Change
21st Apr 20225:30 pmRNSDirector/PDMR Shareholding
23rd Mar 20223:46 pmRNSDirector/PDMR and PCA Shareholding
16th Mar 20227:00 amRNSUnaudited Preliminary Results
9th Mar 20221:17 pmRNSBlock listing Interim Review
7th Mar 20227:00 amRNSNotice of Results
31st Dec 202112:43 pmRNSTotal Voting Rights
16th Dec 20217:00 amRNSFull Year Trading Update
30th Nov 20214:14 pmRNSTotal Voting Rights
4th Nov 20217:00 amRNSAppointment of Adviser
29th Oct 202111:35 amRNSTotal Voting Rights
11th Oct 20213:35 pmRNSHolding(s) in Company
17th Sep 20211:13 pmRNSBlock listing announcement
15th Sep 20217:00 amRNSInterim Results
17th Aug 20217:00 amRNSNotice of Interim Results
2nd Aug 20217:00 amRNSDirectorate Change
30th Jul 20214:35 pmRNSTotal Voting Rights
30th Jul 20213:51 pmRNSHolding(s) in Company
27th Jul 20217:00 amRNSAppointment of Chief Technology Officer
7th Jul 20217:00 amRNSHalf Year Trading Update
30th Jun 20215:24 pmRNSTotal Voting Rights
8th Jun 20212:24 pmRNSResults of Annual General Meeting
8th Jun 20217:00 amRNSAnnual General Meeting
1st Jun 202110:43 amRNSTotal Voting Rights
14th May 202112:10 pmRNSDirector/PDMR Shareholding
4th May 202110:27 amRNSTotal Voting Rights
30th Apr 20215:30 pmRNSAnnual Report, Notice of AGM and Board Change
21st Apr 20216:19 pmRNSDirector/PDMR Shareholding
20th Apr 20217:00 amRNSSeal-G CE Mark Approval
14th Apr 20216:13 pmRNSDirector/PDMR Shareholding
12th Apr 20213:15 pmRNSHolding(s) in Company
29th Mar 202111:00 amRNSDirector/PDMR Shareholding
17th Mar 20217:00 amRNSUnaudited Preliminary Results
8th Mar 202112:24 pmRNSBlock listing Interim Review
4th Mar 20217:00 amRNSNotice of Results
29th Jan 20214:36 pmRNSTotal Voting Rights
22nd Jan 202111:31 amRNSHolding(s) in Company
12th Jan 20217:00 amRNSDirectorate Change
12th Jan 20217:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.